Literature DB >> 14587128

Osteoporosis in older men and women.

Anne M Kenny1, Cherian Joseph, Pamela Taxel, Karen M Prestwood.   

Abstract

Hip fracture incidence accelerates approximately 10 years following the menopause in women and after age 70 in men. Approximately one million Americans suffer fragility fractures each year at a cost of over 14 billion dollars. The disability, mortality and cost of hip and vertebral fractures are substantial in the rapidly growing aging population so that prevention of osteoporosis is a major public health concern. Bone mineral density (BMD) measurement is used to make the diagnosis of osteoporosis prior to incident fracture, and to predict fracture risk. Recommendations for treatment and prevention of osteoporosis based on bone mineral density score published by the World Health Organization and the National Osteoporosis Foundation are outlined.

Entities:  

Mesh:

Year:  2003        PMID: 14587128

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  4 in total

1.  The relationship between bone mineral density and biomechanics in patients with osteoporosis and scoliosis.

Authors:  R Hank Routh; Sara Rumancik; Ram D Pathak; Alan L Burshell; Eric A Nauman
Journal:  Osteoporos Int       Date:  2005-07-06       Impact factor: 4.507

2.  Transiliac bone biopsy in osteoporosis: frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14 years.

Authors:  P H Kann; A Pfützner; G Delling; G Schulz; S Meyer
Journal:  Clin Rheumatol       Date:  2005-05-25       Impact factor: 2.980

3.  STK11 overexpression prevents glucocorticoid-induced osteoporosis via activating the AMPK/SIRT1/PGC1α axis.

Authors:  Jiao Xiao; Wenjin Li; Guojuan Li; Jiankai Tan; Na Dong
Journal:  Hum Cell       Date:  2022-05-11       Impact factor: 4.174

Review 4.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.